Altimmune, Inc.
Late clinical-stage biotech working to improve the lives of those living with serious liver diseases
87 employees · est. 1997 · Gaithersburg, United States
Intercept Pharmaceuticals
Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.
376 employees · est. 2002 · Morristown, United States
Altimmune, Inc. is the older company (1997 vs 2002); Intercept Pharmaceuticals is the larger of the two.
Side-by-Side Comparison
| Metric | Altimmune, Inc. | Intercept Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 1997 older | 2002 |
| Headquarters | ||
| Headquarters | Gaithersburg, United States | Morristown, United States |
| Employees | ||
| Employees | 87 | 376 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $276.40M | $970.05M |
| Funding Rounds | ||
| Funding Rounds | 8 | 8 |
| Services | ||
| Services | development of peptide-based therapeutics, clinical stage research, drug development for liver diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | patients with metabolic dysfunction-associated steatohepatitis, patients with alcohol use disorder, patients with alcohol-associated liver disease, healthcare providers, biopharmaceutical investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Liver Diseases, Clinical-Stage, MASH Therapy, AUD Treatment, ALD Therapy, Glucagon Receptor, GLP-1 Receptor, Dual-Action Therapy, Metabolic Dysfunction, Steatohepatitis, Alcohol Use Disorder, Liver Health | Biopharmaceutical, Liver Diseases, Rare Diseases, Drug Development, Therapeutics, Chronic Autoimmune Liver Diseases, Small Molecule Drugs, Fibrotic Diseases, Metabolic Diseases, Bile Acid Receptors, Chronic Liver Diseases, Non-viral Liver Diseases, Innovation |
| Website | ||
| Website | altimmune.com | interceptpharma.com |
About Altimmune, Inc.
Altimmune, Inc., founded in 1997, is a promising player in the biopharmaceutical sector, carving a niche in the treatment of liver-related diseases. Describing themselves as a "Late clinical-stage biotech working to improve the lives of those living with serious liver diseases," they focus on develo...
About Intercept Pharmaceuticals
Intercept Pharmaceuticals, founded in 2002, is a biopharmaceutical company focused on developing novel therapeutics to treat rare and serious liver diseases such as primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). The company's last investment of $447.70M in Post-IPO...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Altimmune, Inc. and Intercept Pharmaceuticals — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Altimmune, Inc. and Intercept Pharmaceutic... — by email.
Frequently Asked Questions
Compare Altimmune, Inc. with someone else
Start typing a company name or domain.